v3.25.2
STOCKHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Changes in Accumulated Other Comprehensive Income (Loss)

The table below presents changes in AOCI by component for the three and six months ended June 30, 2025 and 2024. All amounts are net of tax (in millions).
Three Months Ended
June 30, 2025
Three Months Ended
June 30, 2024
CTADerivative Hedging Adj.Debt & Equity Securities Adj.Pension Liability Adj.TotalCTADerivative Hedging Adj.Debt & Equity Securities Adj.Pension Liability Adj.Total
Beginning balance$(292)$(6)$(2)$(50)$(350)$(262)$(1)$(3)$(50)$(316)
Other comprehensive income (loss) before reclassifications
112 (36)— (3)73 (27)— (1)(27)
Amounts reclassified from AOCI
— — — — (1)— — 
Net other comprehensive income (loss)
112 (35)— (3)74 (27)— — — (27)
Ending balance
$(180)$(41)$(2)$(53)$(276)$(289)$(1)$(3)$(50)$(343)
Six Months Ended
June 30, 2025
Six Months Ended
June 30, 2024
CTADerivative Hedging Adj.Debt & Equity Securities Adj.Pension Liability Adj.TotalCTADerivative Hedging Adj.Debt & Equity Securities Adj.Pension Liability Adj.Total
Beginning balance$(338)$$(3)$(48)$(382)$(228)$(5)$(3)$(51)$(287)
Other comprehensive income (loss) before reclassifications
158 (50)(6)103 (61)— — (56)
Amounts reclassified from AOCI
— — — (1)— — 
Net other comprehensive income (loss)
158 (48)(5)106 (61)— (56)
Ending balance $(180)$(41)$(2)$(53)$(276)$(289)$(1)$(3)$(50)$(343)
Stock-Based Compensation

During the six months ended June 30, 2025, the Company awarded 0.9 million shares of Restricted Stock to its employees with a weighted average fair value of $40.96 per share. Approximately 62% of these awards are time-based and vest ratably on each of the first three anniversary dates of the grants. Approximately 26% cliff vest at the end of a three-year period and are subject to performance targets that may or may not be met and for which the performance period has not yet been completed. Approximately 12% cliff vest and are based on performance targets containing a market condition determined over a three-year period.

Fair value of time-based awards is based on the market price of our common stock at the date of grant approval. The fair value of performance-based awards, except for awards based on a market condition, is based on the market price of our common stock at the date of grant approval, except fair values are multiplied by the probability of achievement as of the period-end date. For awards based on a market condition, fair value is based on the Monte Carlo method at grant date. The Monte Carlo method is a statistical simulation technique used to provide the grant date fair value of an award. The Company used the Monte Carlo method to determine grant date fair value of $42.06 per share for awards with a market condition granted on March 15, 2025.

The following table presents the weighted-average assumptions used in the valuations:

Grant date
March 15, 2025
Dividend yields1.69 %
Expected volatility41.56 %
Risk free interest rate3.96 %
Expected life (in years)3

Share Repurchases

In July 2018, Terex’s Board of Directors (“Board”) authorized the repurchase of up to $300 million of the Company’s outstanding shares of common stock. In December 2022, Terex’s Board authorized the additional repurchase of up to $150 million of the Company’s outstanding shares of common stock. The table below presents shares repurchased, inclusive of transactions executed but not settled, by the Company under these programs.

Six Months Ended
June 30
Total Number of
Shares Repurchased
Amount of Shares Repurchased
(in millions)
2025
1,360,706$53
2024
345,274$20

Dividends

The table below presents dividends declared by Terex’s Board and paid to the Company’s stockholders:

YearFirst QuarterSecond Quarter
2025
$0.17 $0.17 
2024
$0.17 $0.17 

In July 2025, the Board declared a dividend of $0.17 per share, which will be paid on September 19, 2025 to the Company’s stockholders of record as of August 11, 2025. Additionally, the Board authorized an additional repurchase of up to $150 million of the Company’s outstanding shares of common stock.